PF-06372865
Sponsors
Pfizer
Conditions
Chronic Low Back PainHealthyHealthy VolunteersReflex Epilepsy, Photosensitive
Phase 1
A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06372865 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)
CompletedNCT02070289
Start: 2014-03-31End: 2014-07-31Updated: 2014-08-18
A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865
CompletedNCT02138500
Start: 2014-05-31End: 2014-08-31Updated: 2014-09-25
Food Effect Study for PF-06372865
CompletedNCT02217787
Start: 2014-09-30End: 2014-09-30Updated: 2014-10-27
An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects
WithdrawnNCT02475746
Start: 2015-07-31End: 2015-08-31Updated: 2017-06-26
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects
CompletedNCT03351751
Start: 2017-11-08End: 2018-02-28Updated: 2019-06-03